MIRM (STOCKS)
Mirum Pharmaceuticals, Inc. Common Stock
$101.000000
+1.655000 (+1.67%)
Prev close: $99.345000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christopher Peetz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6,159.10M
- Employees
- 355
- P/E (TTM)
- -7.42
- P/B (TTM)
- 25.38
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.08 | $-0.36 | -0.7196 | -199.67% |
|
Dec 2025 (Q4)
|
$-0.10 | $0.04 | -0.1433 | -330.95% |
|
Sep 2025 (Q3)
|
$0.05 | $-0.17 | +0.2180 | +129.76% |
|
Jun 2025 (Q2)
|
$-0.12 | $-0.33 | +0.2130 | +63.96% |
Financial Statements
| Revenues | $569.61M |
| Benefits Costs and Expenses | $1.37B |
| Costs And Expenses | $1.37B |
| Operating Expenses | $1.37B |
| Selling, General, and Administrative Expenses | $295.65M |
| Other Operating Expenses | $1.07B |
| Operating Income/Loss | -$796.42M |
| Income/Loss From Continuing Operations After Tax | -$798.84M |
| Income/Loss From Continuing Operations Before Tax | -$797.46M |
| Income Tax Expense/Benefit | $1.38M |
| Net Income/Loss | -$798.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$798.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$798.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$13.61 |
| Diluted Earnings Per Share | -$13.62 |
| Basic Average Shares | 159,657,275 |
| Diluted Average Shares | 166,011,885 |
| Assets | $890.92M |
| Current Assets | $569.44M |
| Inventory | $25.52M |
| Other Current Assets | $543.92M |
| Noncurrent Assets | $321.48M |
| Fixed Assets | $2.41M |
| Intangible Assets | $254.15M |
| Other Non-current Assets | $64.91M |
| Liabilities | $648.42M |
| Current Liabilities | $272.82M |
| Accounts Payable | $59.40M |
| Wages | $35.43M |
| Other Current Liabilities | $177.99M |
| Noncurrent Liabilities | $375.60M |
| Equity | $242.49M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $242.49M |
| Liabilities And Equity | $890.92M |
| Net Cash Flow From Operating Activities | -$170.98M |
| Net Cash Flow From Operating Activities, Continuing | -$170.98M |
| Net Cash Flow From Investing Activities | -$19.39M |
| Net Cash Flow From Investing Activities, Continuing | -$19.39M |
| Net Cash Flow From Financing Activities | $303.86M |
| Net Cash Flow From Financing Activities, Continuing | $303.86M |
| Net Cash Flow | $113.50M |
| Net Cash Flow, Continuing | $113.50M |
| Comprehensive Income/Loss | -$799.22M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$798.61M |
| Other Comprehensive Income/Loss | $2.53M |